Browsing: Homepage Slider
0
How well does the Janssen single-dose COVID-19 vaccine work?
A plain language summary of how well the single-dose Janssen vaccine works and how safe it is. The Janssen (Beerse,…
0
Novel cell models for rapid screening of SARS-CoV-2 infection studies
Wednesday 17 November 10:00 [EST] 15:00 [GMT] 16:00 [CET] Available time zones In order to decipher the pathology of COVID-…
0
Download your compendium of objective sample analysis control for infectious disease research
Automated electrophoresis is a powerful tool for microbial, fungal, and viral nucleic acid analysis. The Agilent Fragment Analyzer, Agilent TapeStation,…
0
Long COVID: biomarker and therapeutic discovery
COVID-19 symptoms can persist in an estimated 10% of patients long past recovering from the worst impacts of acute infection…
1
Mucormycosis, the COVID-19 factor and the pressing need for new treatments
Prior to 2021, textbooks about fungal diseases would classify mucormycosis as a very rare infection. However, for the immunosuppressed, mucormycosis…
0
COVID-19: updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
0
In Focus: coronavirus
Discover the latest updates on the ongoing novel coronavirus outbreak in the ‘COVID-19 Hub’, powered by Infectious Diseases Hub and…
6
COVID-19: latest news and figures
The WHO has declared that the COVID-19 outbreak can be characterized as a pandemic as new cases are reported globally, including a huge spike in cases in South Korea, Italy and Iran and over 100 other countries reporting cases.